Vanitha Sekar
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Virology top 2%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 26
- Virology 8
- HIV Research and Treatment 8
- Co-authors
- Richard M. W. Hoetelmans (19 shared papers)Éric Lefebvre (12 shared papers)Monika Peeters (7 shared papers)Martine De Pauw (13 shared papers)Goedele De Smedt (4 shared papers)Tony Vangeneugden (10 shared papers)Oliver Lenz (4 shared papers)David Back (2 shared papers)
- Journals
- Antiviral Therapy (6 papers)British Journal of Clinical Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)The Journal of Clinical Pharmacology (2 papers)AIDS (2 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Vanitha Sekar
33 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 65
- Hepatology 569
- Virology 348
- Infectious Diseases 797
- Emergency Medicine 156
- Epidemiology 404
Countries citing papers authored by Vanitha Sekar
This map shows the geographic impact of Vanitha Sekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanitha Sekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanitha Sekar more than expected).
Fields of papers citing papers by Vanitha Sekar
This network shows the impact of papers produced by Vanitha Sekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanitha Sekar. The network helps show where Vanitha Sekar may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanitha Sekar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 224 | |
| 2 | 2009 | 200 | |
| 3 | 2013 | 185 | |
| 4 | 2008 | 96 | |
| 5 | 2007 | 88 | |
| 6 | 2012 | 86 | |
| 7 | 2007 | 72 | |
| 8 | 2011 | 57 | |
| 9 | 2007 | 41 | |
| 10 | 2007 | 39 | |
| 11 | 2008 | 39 | |
| 12 | 2009 | 38 | |
| 13 | 2010 | 37 | |
| 14 | 2008 | 30 | |
| 15 | 2011 | 29 | |
| 16 | 2012 | 28 | |
| 17 | 2007 | 23 | |
| 18 | 2008 | 19 | |
| 19 | 2007 | 19 | |
| 20 | 2007 | 17 |
About Vanitha Sekar
Vanitha Sekar is a scholar working on Infectious Diseases, Virology, Pediatrics, Perinatology and Child Health, Hepatology and Epidemiology, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers), Hepatitis C virus research (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), HIV-related health complications and treatments (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Hepatology (569 citations), Virology (348 citations), Infectious Diseases (797 citations), Emergency Medicine (156 citations) and Epidemiology (404 citations). Vanitha Sekar has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Richard M. W. Hoetelmans, Éric Lefebvre, Monika Peeters, Martine De Pauw, Goedele De Smedt, Tony Vangeneugden, Oliver Lenz, David Back, Ludo Lavreys and Thomas Berg. Their work appears in journals such as Antiviral Therapy, British Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, The Journal of Clinical Pharmacology and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.